ST. GEORGE’S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 12, 2025 / Atlas Salt Inc. (“Atlas Salt” or the “Company”) (TSXV:SALT)(OTCQB:REMRF) announces that it has signed a comprehensive ...

Corneal crosslinking failure rates were low in a US registry analysis, but CXL failure risk was doubled for patients aged younger than 18 years.

Integrating Nym AI requires a clear plan that looks at both the technology and the people involved. By assessing current ...